Lesson plan
Dalkon Shield
The Dalkon Shield was a contraceptive intrauterine device (IUD) developed by the Dalkon Corporation and marketed by the A.H. Robins Company. First marketed in 1971, it was promoted as a safer alternative to birth control pills and was used by about 2.2 million women in the United States at its peak. The device was associated with an increased risk of septic abortion and other severe infections, largely because its multifilament tail string could allow bacteria to pass through the cervix into the uterus. Sales were suspended in the United States in 1974 at the urging of the Food and Drug Administration, although the device continued to be marketed internationally for several years. More than 327,000 lawsuits and claims were filed against A.H. Robins over the Dalkon Shield, making it one of the largest product-liability cases in U.S. history. The resulting litigation led the company to file for Chapter 11 bankruptcy protection in 1985 and contributed to the passage of the 1976 Medical Device Amendments, which for the first time required the U.S. Food and Drug Administration to regulate medical devices, including IUDs.
Article summary
The Dalkon Shield was a contraceptive intrauterine device (IUD) developed by the Dalkon Corporation and marketed by the A.H. Robins Company. First marketed in 1971, it was promoted as a safer alternative to birth control pills and was used by about 2.2 million women in the United States at its peak. The device was associated with an increased risk of septic abortion and other severe infections, largely because its multifilament tail string could allow bacteria to pass through the cervix into the uterus. Sales were suspended in the United States in 1974 at the urging of the Food and Drug Administration, although the device continued to be marketed internationally for several years. More than 327,000 lawsuits and claims were filed against A.H. Robins over the Dalkon Shield, making it one of the largest product-liability cases in U.S. history. The resulting litigation led the company to file for Chapter 11 bankruptcy protection in 1985 and contributed to the passage of the 1976 Medical Device Amendments, which for the first time required the U.S. Food and Drug Administration to regulate medical devices, including IUDs.
Key claims
No claims recorded.
Discussion questions
- Summarise the article in your own words. Which single claim would you verify first, and why?
- Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
- If two sources disagreed about one of these facts, what would you need in order to trust one over the other?
Bibliography
No sources recorded.
Key claims and bibliography are generated from the same tracked claims and sources as the article page.